Robert de Luccia

Mr. Robert J.
de Luccia is an Executive Chairman at Acurx Pharmaceuticals, Inc. and a Lead Independent Director at IBEX Technologies, Inc. He is on the Board of Directors at PLx Pharma, Inc. and IBEX Technologies, Inc. Mr. de Luccia was previously employed as an Executive Chairman by Dipexium Pharmaceuticals, Inc., a Chairman, President & Chief Executive Officer by MacroChem Corp., a President & Chief Executive Officer by Immunomedics, Inc., a Chief Executive Officer by Morris Plains Property LLC, a Vice President-Marketing & Sales Operations by Pfizer Inc., a President by Sanofi Winthrop, a President by Sanofi-Aventis U.S.
LLC, and a President by Sterling Winthrop, Inc. He also served on the board at Topigen Pharmaceuticals, Inc. He received his undergraduate degree from Iona College and an MBA from Iona College.